BPG is committed to discovery and dissemination of knowledge
Citation
Zhou SQ, Wan P, Zhang S, Ren Y, Li HT, Ke QH. Programmed cell death 1 inhibitor sintilimab plus concurrent chemoradiotherapy for locally advanced pancreatic adenocarcinoma. World J Clin Oncol 2024; 15(7): 859-866 [PMID: 39071470 DOI: 10.5306/wjco.v15.i7.859]
Please LOGIN to submit a new comment.